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The cloningof recombinant proteins offers the possibility ofproducing, identifying,
and manipulating the important IgE-binding determinants present on proteins that
are responsible for provoking allergic diseases (1). Proteins produced by mites of
the genus Dermatophagoides are among the most important allergens affecting man
in terms of both the frequency of the response by allergic subjects and the propor-
tion oftotal IgE directed against these allergens (2, 3). Ofthe 30 or more IgE-binding
components demonstrated by our blotting studies (2, 4), at least six may be impor-
tant allergens on the basis oftheir frequency and intensity of IgE binding on blots.
Only two ofthese, DerpI and Derp II, have been extensively investigated. The cDNA
coding for Derp I has recently been cloned and sequenced (5), although the recom-
binant protein did not bind IgE.
A cDNA library expressing recombinant mite proteins has been screened using
IgE antibodies from mite-allergic subjects. Techniques based on protein blotting have
been used to identify the native source of an IgE-binding recombinant protein as
the important mite allergen of molecular weight -14,000.
Materials and Methods
HouseDust Mite Extracts.
￿
For mRNA preparation, live mites were harvested from culture
by centrifugation on NaCI density gradients. For protein blotting, extracts of dried mites
containing 10 mg protein/ml were prepared from commercial dried mites, as previously de-
scribed (2).
LabeledAntisera andHuman Sera Used.
￿
For screening the cDNA library, goat anti-human
IgE antibodies (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) labeled with 1251
(6) were used. For probing the initial blots of native dust mite extract and inclusion bodies,
1251-anti IgE (Kallestad, Austin, TX) was used; for detecting the reprobing of eluted IgE,
alkaline phosphatase-labeled anti-IgE (Kallestad) was used. Human sera from mite-allergic
subjects was provided by the Allergy Department, Royal North Shore Hospital, from sub-
jects who showed a strong skin-prick test response to mite extract. The pool of mite allergic
sera was prepared by combining 20 sera. Before use, the sera from mite allergic subjects was
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preabsorbed with extracts of Escherichia coli strain RY 1089 X gt 11 lysogen to remove IgE
directed against those proteins that would otherwise interfere with the screening ofthe cDNA
library.
Production and Screening ofcDNA Library to D. pteronyssinus Mites.
￿
mRNA from live mites
was prepared using guanidine isothiocyanate extraction and affinity purified using oligo-
dT-cellulose (no. 20003 ; Collaborative Research, Lexington, MA) (7). A cDNA library
was prepared in X gt 11 (cDNA kit no. RPN 1256; Amersham Corp., Arlington Heights,
IL) according to the manufacturer's directions. The primary cDNA library of 1.7 x 105
recombinants was amplified to generate a high titre stock. The library was immunoscreened
(_105 PFU/plate) using serum pooled from mite-allergic subjects following the Amersham
protocol. IgE-binding clones were detected using '251-labeled anti-human IgE antibodies and
autoradiography and were purified to single plaques.
Purified recombinant bacteriophage representing the IgE-binding clones were used to in-
fect E. coli strain Y1089 to produce fusion polypeptides (8). The IgE-binding polypeptides
were identified on protein blots of the lysogen extracts by probing with mite-allergic serum
as above. Large scale preparation of the fusion polypeptides was carried out (8).
Identification of the Native Allergen that Shares IgE-binding Determinants with the Cloned Pro-
tein. Electroblotting of unreduced mite extracts after SDS-PAGE on 9-2717o gradient gels
(SE-400; Hoeffer Scientific Instruments, San Francisco, CA) was performed as previously
described (2). The inclusion bodies derived from the phage-infected E. coli lysogen containing
the recombinant protein were solubilized in 2.5o7o SDS, 100 mM DTT, 20 mM Tris, pH 7.5,
10 mM EDTA, and 1 mM PMSF by heating at 100°C for 30 min, and were separated on
18% homogeneous gels (Mini-Protean II apparatus; Bio-Rad Laboratories, Richmond, CA).
Each blot of mite bodies and inclusion bodies were divided into two portions, and one por-
tion was stored at 4'C. The remaining portion was incubated in l05 Jo pooled mite-atopic
serum in PBS, 0.1% sodium azide overnight. The position of IgE-binding components on
the blots were located using narrow vertical strips cut from each edge of the blot after in-
cubated with "5I-anti-IgE and autoradiography. The major IgE-binding horizontal band
(N30-40 mm long x 2-3 mm wide) was excised from blot of inclusion bodies, and six major
IgE-binding bands were excised from the blot of mite bodies. An additional strip that did
not bind IgE was also excised from the bottom of each blot to function as a control. Each
strip was cut into pieces _2 mm2 and IgE was eluted by six cycles of gentle vortexing for
1 min each with 100 /Al of 0.1 M Glycine-HCI, pH 2.5, 1% (wt/vol) BSA, followed by im-
mediate neutralization with a 3 M Tris-HCl solution, pH 8.8, to give a final pH of 7.0. So-
dium azide was added to a final concentration of 0.1% (wt/vol). The solution containing the
antibodies eluted from the inclusion body blot was incubated overnight with a stored strip
from the mite blot. Similarly, solutions containing the IgE eluted from the six bands of the
blot of mite body extract were incubated with strips from the blot of the inclusion bodies.
The position of binding of the IgE was located with enzyme-labeled anti-IgE. As an addi-
tional control for specificity, IgE samples originally eluted from the blot of the inclusion bodies,
after incubation with the mite blot, were then incubated with strips from the blot of the inclu-
sion bodies. Similar controls were performed with IgE from the mite blots.
Sequencing ofcDNA.
￿
DNA was prepared from the selected IgE-binding cDNA bacterio-
phage clone (8) and the cDNA insert excised byEco RI digestion (7), purified after separation
on low melting point agarose, and ligated into the plasmid pBTA 502 (Biotechnology, Sydney,
Australia). After transformation in the E. coli strainJM109 and the isolation of transformed
colonies, plasmid DNA was prepared (9). DNA sequencing was carried out on an alkali-
denatured plasmid template using a 17-mer primer (no. 1211; New England Biolabs, Beverly,
MA) and the enzyme Sequenase (United States Biochemical Corp., Cleveland, OH) according
to the manufacturer's directions. 35S-labeled products were run on 8% polyacrylamide gels
for 2 and 4 h, autoradiographed overnight, and the sequence ofthe first 250 bases was deter-
mined. For further sequencing, a set of nested deletions was created using the "Erase-a-base"
Exo III/S1 nuclease system (Promega Biotec, Madison, WI).
Results
Identification oftheMite Component Corresponding to the RecombinantMite Protein.
￿
Blots
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a major IgE-binding component of mol wt "150,000 (Fig . 1 b), whereas blots of
nonrecombinant bacterial lysate did not bind IgE (not shown) . IgE eluted from this
componenton an excisedportionof the recombinant blot (Fig . 1 b, position 1), when
incubated with a strip from a blot of mite extract, bound to a component of mol
wt ti 14,000 (Fig. 1 e) . The position on the gels of the component of mol wt 14,000
was ofamolwt ti 1,000 less than Derp II . The same procedure was carried out with
the control non-IgE-binding portion of inclusion body blot (Fig . 1 b, position 2)
and no binding of IgE to the mite blot was detected (not shown) . When, after incu-
bation with the mite blots, these eluates were reincubated with recombinant blots,
the eluted IgE only bound to the inclusion body component of mol wt ti 150,000
(not shown) . Similarly, when IgE eluted from the major IgE-binding bands of a
mite blot (Fig . 1 d, positions 1-6) and a seventh control position (not shown) were
incubated with strips from the inclusion body blot, strong IgE binding was only
detected with IgE eluted from position 6 of the mite strip (Fig . 1f) and not with
IgE eluted from otherpositions (not shown) . When the eluted IgE was reincubated
with mite strips, with one exception, each fraction only bound to the component
it was eluted from (results not shown) . Theexception was IgE eluted from the com-
ponent of mol wt 30,000, which bound to the components of mol wt 30,000, and
to a lesser extent to the component of mol wt 25,000 (not shown) .
Sequence ofthecDNA .
￿
ThecDNA sequence and the deduced aminoacid sequence
derivedfrom thecDNA insert isshown in Fig. 2 . Theinsert corresponds to a 148-amino
acid polypeptideof estimated molwt 17,460 and contains no cysteine or tryptophan .
At the level of 20 matchedbasesno homology was foundbetween this sequence and
otherDNA sequences using theIntegenetics IFIND programme (ItelliGenetics, Inc.,
Mountain View, CA) to search the NIH database .
FIGURE 1 . Protein staining and immuno-
probing ofblots of inclusion bodies containing
an IgE-binding recombinant mite protein and
of a mite body extract. The following are
shown : (a) CBB staining of inclusion body
proteins separated by SDS-PAGE . The posi-
tion ofmolecular mass markers shown as black
bars are as follows (200, 116, 92, 65, and 45
kD). (b) Autoradiograph of a protein blot of
inclusion bodies showing the position of the
IgE-binding component . The position of the
bands that were excised for the preparation
by elutionofclone-specific IgEand ofan IgE-
free control band are marked as 1 and 2,
respectively, on the strip . (c)CBB staining of
protein components ofa miteextract separated
by SDS-PAGE . The position of molecular
mass markers 93, 66, 45, 31, 21, and 14.4 kD
are shownby black bars . (d) Autoradiograph
of a protein blot of the mite extract showing
the position of IgE-binding components and
the position ofthe six bands that were excised
and used for preparation of specific IgE are
marked 1-6, a seventh control band was excised from the bottom of the strip in a region notbinding
IgE . (e) A strip of a blot of a mite body extract showing the position of binding of IgE eluted from
position 1 ofa blot of recombinant inclusion bodies stained using enzyme-labeled anti-IgE . (f) A strip
from a blot of recombinant inclusion bodies showing the position of rebinding of specific IgE eluted
from position 6 of a mite blot using enzyme-labeled anti-IgE .1460
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CTT TTT CTC GAA AAT AAA GAT CCC AAA CCG TTA AAA AAA ATA
￿
14
Leis Phe Leu Glu Asn Lys ASP Pro Lys Pro Leu Lys Lys Ile
TCA ATC ATG AAA TTC ATC ATT GCT TTC TTT GTT GCC ACT TTG
￿
28
Ser Ile Met Lys Phe Ile Ile -Ala Phe Phe Val Ala Thr Leu
GCA GTT ATG ACT GTT TCA GGT GAA GAT AAA AAA CAT GAT TAT
￿
42
Ala Val Met Thr Val Ser Gly GIu Asp Lys Lys His Asp Tyr
CAA AAT GAA TTT GAT TTC TTA TTG ATG GAA CGT ATT CAT GAA 56
Gin Asn Glu Phe Asp Phe Leu Leu Met Glu Arg Ile His Glu
CAA ATT AAA AAA GGT GAA CTT GCA TTG TTC TAT CTT CAA GAA
￿
70
Gln Ile Lys Lys Gly Glu Leu Ala Leu Phe Tyr Leu Gln Glu
CAG ATT AAT CAT TTT GAA GAA AAA CCA ACA AAA GAA ATG AAA
￿
84
Gln Ile Asn His Phe Glu Glu Lys Pro Thr Lys Glu Met Lys
GAT AAA ATT GTA GCC GAA ATG GAT ACC ATT ATT GCT ATG ATC
￿
98
Asp Lys Ile Val Ala Glu Met Asp Thr Ile Ile Ala Met Ile
GAT GGT GTA CGT GGT GTA CTT GAT CGT CTT ATG CAA CGT AAA 112
Asp Gly Val Arg Gly Val Leu Asp Arg Leu Met Gln Arg Lys
GAT TTA GAT ATT TTT GAA CAA TAT AAT CTT GAA ATG GCT AAA
￿
126
Asp Leu Asp Ile Phe Glu Gln Tyr Asn Leu Glu Met Ala Lys
AAA TCT GGT GAT ATT TTG GAA CGT GAT TTG AAA AAA GAA GAA 140
Lys Ser Gly Asp Ile Leu Giu Arg Asp Leu Lys Lys Glu Glu
GCA CGT GTT AAA AAG ATT GAA GGT TAA
Ala Arg Val Lys Lys Ile Glu Val *.*
FIGURE 2.
￿
Nucleotide and predicted amino
acid sequence ofthe cDNA whose expression
product shares the IgE-bindingdeterminants
with a component of mite extracts of mol wt
-14,000. The numbers at the right refer to
amino acid positions. These sequence data
have been submitted to the EMBL/GenBank
Data Libraries.
Comparison ofIgE Binding to Blots ofthe Recombinant Mite Protein and the Corresponding
Component ofMite Extracts. Ofthe 38 sera tested, 16 did not bind to either the region
of the recombinant blot corresponding to components of 150,000 or the region of
the mite blots corresponding to mol wt 14,000, two bound weakly to the mite blot
only and five bound weakly to the recombinant blot only. All of the remaining 15
sera bound with similar intensities to both blots.
Discussion
The results demonstrate the cloning of an IgE-binding recombinant mite poly-
peptide recognized by abouthalfthe sera from amite-allergic group of subjects tested.
A similar frequency of recognition for the corresponding component on mite blots
has been demonstrated in otherprotein blotting studies from this laboratory using
agreater number of sera (4). This component is one of six, of the total of>30, sug-
gested to be important allergens of D . pteronyssinus (2, 4).
The blotting strategy used here to identify proteins extracted from anative source
carrying the same IgE-binding determinants as the cloned inclusion polypeptides
should be generally applicable to the cloning of other allergens. The specificity of
the antibody recognition was maximizedby the followingapproaches. The sera used
were preabsorbed with a lysate ofE . coli infected with the phage lacking the cDNA
insert to eliminate the possibility of IgE binding to E. coli proteins. The IgE was
eluted from blots ofboth the native material and the recombinant polypeptides and
then bound to blots of the recombinant polypeptides and native material, respec-
tively. The eluted IgE was shown to faithfully bind to the original blotted source.
The precise molecular weight of the native mite component corresponding to the
recombinant protein was not determined. On unreduced SDS-PAGE gels the com-
ponent had a mol wt of "14,000, -1,000 less than the allergen Der p II. Der p II
hasamolwt of 15,000-16,000by SDS-PAGE, and amolwt of 14,131 based on amino
acid analysis. Differences between molecularweight values based on electrophoretic
migration on SDS-PAGE and sequence data are not uncommon (10) and such dis-
crepancies are more pronounced for low molecular weight proteins (11).TOVEY ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
1461
From thepredicted amino acid sequence, themolecular weight ofthecloned mite
allergen is -3,000 greater than the molecular weight determined by nonreducing
SDS-PAGE forthecorresponding blotted mite component. It may be that thenative
(mature) componentin mite extracts lacks some of the terminal amino acids present
in the recombinant protein. A possibility may be the leader sequence, usually of
19-21 amino acids associated with proteins made on membrane-bound ribosomes
and normally cleaved offpost-translationally during membrane transport (12). The
deduced amino acid sequence from a cDNA clone of Derp I was demonstrated to
contain an additional 23 amino acids when compared with the amino acid sequence
of native Der p I purified from mite extracts (5).
The strong correlation betweenthe intensity and specificity of binding of IgE from
apanel of sera to the electroblotted blotted recombinant protein, and a component
of mol wt -14,000 on blots of the native mite extract, suggests a potential use of
such recombinant material for specific diagnostic applications. An aim of the ap-
proach described here is to assemble a panel of mite recombinant proteins that in-
clude all of the important IgE-bindingdeterminants. Such a selected panel maybe
more amenable to standardization than the highly variable crude extracts currently
available from native sources. Cloned allergens may also be more amenable to
modifications, making them saferand more suitable forimmunotherapy. Considering
the slow progress isolatingindividual allergens to date, recombinant DNA methods
may offer great potential for the future production and sequencing of allergens and
for the identification of allergenic determinants.
Summary
A cDNA clone coding for a mite allergen of mol wt -14,000 has been isolated
and its DNA sequence determined. The native component from mite extracts en-
coded by this DNA was identified by immunoprobing blots of mite body extract
with human IgE eluted from the electroblotted cloned fusion polypeptides derived
from the expressed cDNA clone. The clone encodes a polypeptide with a deduced
mol wt of 17,460. The deduced amino acid sequence was not homologous to any
known protein sequences and it contains no cysteine or tryptophan. On blots, 21
of 38 sera from mite-allergicsubjects recognized the cloned material, andthis recog-
nition strongly correlated with IgE-bindingto the native component on proteinblots
of mite extract.
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